OBJECTIVE: To analyze clinical, histological, and immunohistochemical prognostic factors in a large series of patients with mucoepidermoid carcinoma (MEC) treated in a single institution, using univariate and multivariate survival analyses. DESIGN: Inception cohort. SETTING: Referral center. PATIENTS: All patients diagnosed with head and neck MEC from a single cancer referral center from January 19, 1957, to July 12, 1997. MAIN OUTCOME MEASURES: Rates of local recurrence, regional and distant metastasis, and overall actuarial survival. RESULTS: Men represented 53.8% of the cohort, and the parotid gland and palate were affected by MEC in 35.2% and 23.7%, respectively. TNM stage I or II lesions comprised 50.3% of the tumors, and low-grade tumors comprised 45.2%, and the 5-year overall survival was 70.2%. Univariate survival analysis revealed that age older than 40 years (P<.001), male sex (P=.005), fixed tumors (P=.002), invasion of adjacent structures (P=.004), T stage (P<.001), N stage (P<.001), clinical stage (P<.001), histological grade (P<.001), and expression of proliferating cell nuclear antigen (P<.001), Ki-67 (P<.001), and p53 (P<.001) correlated with a poor prognosis. Expression of carcinoembryonic antigen (P=.01) and bcl-2 (P<.001) correlated with a better prognosis. CONCLUSION: Age older than 40 years, fixed tumors, T and N stage, and histological grade are independent significant prognostic factors in patients with MEC.
OBJECTIVE: To analyze clinical, histological, and immunohistochemical prognostic factors in a large series of patients with mucoepidermoid carcinoma (MEC) treated in a single institution, using univariate and multivariate survival analyses. DESIGN: Inception cohort. SETTING: Referral center. PATIENTS: All patients diagnosed with head and neck MEC from a single cancer referral center from January 19, 1957, to July 12, 1997. MAIN OUTCOME MEASURES: Rates of local recurrence, regional and distant metastasis, and overall actuarial survival. RESULTS:Men represented 53.8% of the cohort, and the parotid gland and palate were affected by MEC in 35.2% and 23.7%, respectively. TNM stage I or II lesions comprised 50.3% of the tumors, and low-grade tumors comprised 45.2%, and the 5-year overall survival was 70.2%. Univariate survival analysis revealed that age older than 40 years (P<.001), male sex (P=.005), fixed tumors (P=.002), invasion of adjacent structures (P=.004), T stage (P<.001), N stage (P<.001), clinical stage (P<.001), histological grade (P<.001), and expression of proliferating cell nuclear antigen (P<.001), Ki-67 (P<.001), and p53 (P<.001) correlated with a poor prognosis. Expression of carcinoembryonic antigen (P=.01) and bcl-2 (P<.001) correlated with a better prognosis. CONCLUSION: Age older than 40 years, fixed tumors, T and N stage, and histological grade are independent significant prognostic factors in patients with MEC.
Authors: Zachary C Taylor; Erin A Kaya; Jeffrey D Bunn; Zachary D Guss; Brian J Mitchell; Robert K Fairbanks; Wayne T Lamoreaux; Aaron E Wagner; Ben J Peressini; Christopher M Lee Journal: World J Clin Oncol Date: 2020-12-24
Authors: Ana P D Demasi; Ana F Costa; Albina Altemani; Cristiane Furuse; Ney S Araújo; Vera C Araújo Journal: Int J Exp Pathol Date: 2010-01-21 Impact factor: 1.925
Authors: N Kashiwagi; K Dote; K Kawano; Y Tomita; T Murakami; K Nakanishi; Y Araki; K Mori; N Tomiyama Journal: Br J Radiol Date: 2011-09-06 Impact factor: 3.039
Authors: Serena A Byrd; Matthew E Spector; Thomas E Carey; Carol R Bradford; Jonathan B McHugh Journal: Otolaryngol Head Neck Surg Date: 2013-05-21 Impact factor: 3.497